Point72 Hong Kong LTD Lyell Immunopharma, Inc. Transaction History

Point72 Hong Kong LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$3.68 - $6.8 $49,676 - $91,793	-13,499 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$5.05 - $7.7 $68,169 - $103,942	13,499 New	13,499 $68,000
Q3 2021 Nov 15, 2021	SELL	$11.0 - $17.95 $312,477 - $509,905	-28,407 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$15.99 - $16.89 $454,227 - $479,794	28,407 New	28,407 $461,000

121

142M

18.1K

200

Ticker LYEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 247,824,992
Market Cap $151M
Description
Lyell Immunopharma, Inc., a T cell reprogramming company, engages in developing T cell therapies for patients with solid tumors. The company develops therapies using technology platforms, such as Gen-R, an ex vivo genetic reprogramming technology to overcome T cell exhaustion; and Epi-R, an ex vivo epigenetic reprogramming technology to generate...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.